Development of (166)Ho-phytate Complex for Radiosynovectomy.

Amir R Jalilian1, Akbar Anvari2, Ali Bahrami-Samani1

  • 1Radiopharmaceutical Research and Development Laboratory (RRDL), Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran 14155-1339.

Summary

Holmium-166 phytate demonstrated excellent retention at the injection site for two days post-intraarticular administration in rats. This suggests its potential as a targeted radiotherapeutic agent for joint conditions.

Related Concept Videos